N-(2-methoxycarbonylethylsulfonyl)-6-chloro-1,2,3,4-tetrahydroisoquinoline | 111875-08-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四氢异喹啉
• 英文名称: N-(2-methoxycarbonylethylsulfonyl)-6-chloro-1,2,3,4-tetrahydroisoquinoline
• 英文别名: Methyl 3-[(6-chloro-3,4-dihydroisoquinolin-2(1H)-yl)sulfonyl]propionate；methyl 3-[(6-chloro-3,4-dihydro-1H-isoquinolin-2-yl)sulfonyl]propanoate
• CAS: 111875-08-2
• 化学式: C₁₃H₁₆ClNO₄S
• 分子量: 317.793
• InChiKey: BAHDWHOMCBEZMA-UHFFFAOYSA-N

物化性质

• 熔点：
  81-82 °C(Solv: ethanol (64-17-5))
• 沸点：
  468.3±55.0 °C(Predicted)
• 密度：
  1.40±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  72.1
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  N-(2-methoxycarbonylethylsulfonyl)-6-chloro-1,2,3,4-tetrahydroisoquinoline 在 盐酸 作用下， 以 叔丁醇 为溶剂， 反应 10.0h， 生成 6-氯-1,2,3,4-四氢异喹啉
  参考文献：
  名称：

  Orazi, Orfeo O.; Corral, Renee A.; Giaccio, Hector, Journal of the Chemical Society. Perkin transactions I, 1986, p. 1977 - 1982

  摘要：

  DOI：
• 作为产物：
  描述：

  间氯氰苄 在 sodium tetrahydroborate 、 甲烷磺酸 、 四氯化锡 、 potassium carbonate 作用下， 以 水 、 乙酸酐 、 1,2-二氯乙烷 、 甲苯 、 苯 为溶剂， 反应 24.5h， 生成 N-(2-methoxycarbonylethylsulfonyl)-6-chloro-1,2,3,4-tetrahydroisoquinoline
  参考文献：
  名称：

  Orazi, Orfeo O.; Corral, Renee A.; Giaccio, Hector, Journal of the Chemical Society. Perkin transactions I, 1986, p. 1977 - 1982

  摘要：

  DOI：

文献信息

• Efficient and suitable preparation of N-sulfonyl-1,2,3,4-tetrahydroisoquinolines and ring analogues using recyclable H6P2W18O62·24H2O/SiO2 catalyst
  作者：Gustavo Pasquale、Diego Ruiz、Juan Autino、Graciela Baronetti、Horacio Thomas、Gustavo Romanelli

  DOI：10.1016/j.crci.2012.05.016

  日期：2012.9

  Résumé Silica gel-supported H6P2W18O62·24H2O is an efficient and recyclable catalyst for the synthesis of biologically important molecules. Several substituted N-sulfonyl-1,2,3,4-tetrahydroisoquinolines and ring analogues can be prepared in very good yields and purity by direct reaction of N-aralkylsulfonamides and sym-trioxane by a Pictet-Spengler reaction in the presence of a catalytic amount of silica gel-supported H6P2W18O62·24H2O. Reactions were performed in a low volume of toluene, at 70 °C and for a short time, typically 15 to 30 min. The title heterocyclic compounds were prepared in very good yields (60%–95%) using the described procedure results in a clean and useful alternative, which has the advantages of a greener methodology with operative simplicity, use of a reusable and non-corrosive solid catalyst, soft reaction conditions, low reaction times, and good yields.

  摘要 硅胶支撑的 H6P2W18O62-24H2O 是一种高效且可回收的催化剂，可用于合成重要的生物分子。在一定量的硅胶支撑的 H6P2W18O62-24H2O 催化下，N-芳基磺酰胺与交三氧杂环己烷通过皮克泰-斯彭勒反应直接反应，可以制备出几种取代的 N-磺酰基-1,2,3,4-四氢异喹啉和环类似物，而且产率和纯度都非常高。反应在低浓度甲苯中进行，温度为 70 °C，时间很短，一般为 15 至 30 分钟。使用所述步骤制备的标题杂环化合物收率非常高（60%-95%），是一种清洁、有用的替代方法，具有操作简单、使用可重复使用的非腐蚀性固体催化剂、反应条件温和、反应时间短和收率高的优点。
• Imidazole derivative, process for producing the same, and use
  申请人：Kubo Keiji

  公开号：US20070004736A1

  公开（公告）日：2007-01-04

  There is provided an imidazole derivative useful as a thrombosis treating agent, which is represented by the formula (I): wherein R represents an optionally substituted cyclic hydrocarbon group or an optionally substituted heterocyclic group, W represents a bond or an optionally substituted divalent linear hydrocarbon group, X represents an optionally substituted divalent hydrocarbon group, Y represents —CO—, —S(O)—, —S(O) 2 — or a bond, ring A represents an optionally substituted pyrrolidine ring, an optionally substituted piperidine ring or an optionally substituted perhydroazepine ring, Z 1 and Z 3 independently represent a bond or an optionally substituted divalent linear hydrocarbon group, Z 2 represents —N(R 1 )—, —O—, —S(O)—, —S(O) 2 —, —CO—, —CH(R 1 )— or a bond, ring B represents an optionally substituted imidazole ring, wherein a substituent which the optionally substituted imidazole ring represented by ring B may have may be taken together with R 1 to form an optionally substituted ring, and a represents 0, 1 or 2.

  提供了一种咪唑衍生物，用作治疗血栓的药物，其化学式表示为(I)式：其中R代表可选取代的环烃基或可选取代的杂环基，W代表键或可选取代的二价直链烃基，X代表可选取代的二价烃基，Y代表-CO-、-S(O)-、-S(O)2-或键，环A代表可选取代的吡咯烷环、可选取代的哌啶环或可选取代的过氢杂环己烷环，Z1和Z3独立地代表键或可选取代的二价直链烃基，Z2代表-N(R1)-、-O-、-S(O)-、-S(O)2-、-CO-、-CH(R1)-或键，环B代表可选取代的咪唑环，其中可选取代的咪唑环所具有的取代基可以与R1一起形成可选取代的环，a代表0、1或2。
• IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE
  申请人：KUBO Keiji

  公开号：US20110009389A1

  公开（公告）日：2011-01-13

  There is provided an imidazole derivative useful as a thrombosis treating agent, which is represented by the formula (I): wherein R represents an optionally substituted cyclic hydrocarbon group or an optionally substituted heterocyclic group, W represents a bond or an optionally substituted divalent linear hydrocarbon group, X represents an optionally substituted divalent hydrocarbon group, Y represents —CO—, —S(O)—, —S(O) 2 — or a bond, ring A represents an optionally substituted pyrrolidine ring, an optionally substituted piperidine ring or an optionally substituted perhydroazepine ring, Z 1 and Z 3 independently represent a bond or an optionally substituted divalent linear hydrocarbon group, Z 2 represents —N(R 1 )—, —O—, —S(O)—, —S(O) 2 —, —CO—, —CH(R 1 )— or a bond, ring B represents an optionally substituted imidazole ring, wherein a substituent which the optionally substituted imidazole ring represented by ring B may have may be taken together with R 1 to form an optionally substituted ring, and a represents 0, 1 or 2.

  提供了一种咪唑衍生物，可用作治疗血栓的药物，其化学式表示为（I）：其中R代表可选取代的环烃基或可选取代的杂环基，W代表键或可选取代的二价线性烃基，X代表可选取代的二价烃基，Y代表-CO-，-S（O）-，-S（O）2-或键，环A代表可选取代的吡咯烷环，可选取代的哌啶环或可选取代的过氢化脂肪环，Z1和Z3独立地代表键或可选取代的二价线性烃基，Z2代表-N（R1）-，-O-，-S（O）-，-S（O）2-，-CO-，-CH（R1）-或键，环B代表可选取代的咪唑环，其中可选取代的咪唑环所代表的取代基可以与R1一起形成可选取代的环，a代表0，1或2。
• IMIDAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP1564213A1

  公开（公告）日：2005-08-17

  There is provided an imidazole derivative useful as a thrombosis treating agent, which is represented by the formula (I): wherein R represents an optionally substituted cyclic hydrocarbon group or an optionally substituted heterocyclic group, W represents a bond or an optionally substituted divalent linear hydrocarbon group, X represents an optionally substituted divalent hydrocarbon group, Y represents -CO-, -S(O)-, -S(O)2- or a bond, ring A represents an optionally substituted pyrrolidine ring, an optionally substituted piperidine ring or an optionally substituted perhydroazepine ring, Z1 and Z3 independently represent a bond or an optionally substituted divalent linear hydrocarbon group, Z2 represents -N(R1)-, -O-, - S(O)-, -S(O)2-, -CO-, -CH(R1)- or a bond, ring B represents an optionally substituted imidazole ring, wherein a substituent which the optionally substituted imidazole ring represented by ring B may have may be taken together with R1 to form an optionally substituted ring, and a represents 0, 1 or 2.

  提供了一种咪唑衍生物，可用作血栓治疗剂，其由式(I)表示： 其中 R 代表任选取代的环状烃基或任选取代的杂环基，W 代表键或任选取代的二价线性烃基，X 代表任选取代的二价烃基，Y 代表 -CO-、-S(O)-、-S(O)2- 或键，环 A 代表任选取代的吡咯烷环、任选取代的哌啶环或任选取代的全氢氮杂卓环、Z1 和 Z3 独立地代表键或任选取代的二价线性烃基，Z2 代表-N(R1)-、-O-、-S(O)-、-S(O)2-、-CO-、-CH(R1)- 或键，环 B 代表任选取代的咪唑环，其中环 B 所代表的任选取代的咪唑环可能具有的取代基可与 R1 一起形成任选取代的环，a 代表 0、1 或 2。
• EP1564213
  申请人：——

  公开号：——

  公开（公告）日：——